A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity
Clinical trial NCT07724340 · RECRUITING
Trial details
- NCT number
- NCT07724340
- Sponsor
- Antag Therapeutics
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-19
- Primary completion
- 2027-02-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.